NDC 58160-885

FLUARIX QUADRIVALENT 2020/2021

Influenza Virus Vaccine

FLUARIX QUADRIVALENT 2020/2021 is a Intramuscular Suspension in the Vaccine category. It is labeled and distributed by Glaxosmithkline Biologicals Sa. The primary component is Influenza A Virus A/guangdong-maonan/swl1536/2019 Cnic-1909 (h1n1) Antigen (formaldehyde Inactivated); Influenza A Virus A/hong Kong/2671/2019 Nib-121 (h3n2) Antigen (formaldehyde Inactivated); Influenza B Virus B/washington/02/2019 Antigen (formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated).

Product ID58160-885_797e9f6a-d957-4f20-8fac-5f1ac8b1de31
NDC58160-885
Product TypeVaccine
Proprietary NameFLUARIX QUADRIVALENT 2020/2021
Generic NameInfluenza Virus Vaccine
Dosage FormSuspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2020-07-02
Marketing End Date2021-06-30
Marketing CategoryBLA / BLA
Application NumberBLA125127
Labeler NameGlaxoSmithKline Biologicals SA
Substance NameINFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 NIB-121 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)
Active Ingredient Strength15 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
NDC Exclude FlagN

Packaging

NDC 58160-885-52

10 SYRINGE in 1 CARTON (58160-885-52) > .5 mL in 1 SYRINGE (58160-885-41)
Marketing Start Date2020-07-02
Marketing End Date2021-06-30
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "FLUARIX QUADRIVALENT 2020/2021" or generic name "Influenza Virus Vaccine"

NDCBrand NameGeneric Name
58160-885FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-887FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-890FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-896FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-898FLUARIX QUADRIVALENTinfluenza virus vaccine
19515-808Flulaval Quadrivalentinfluenza virus vaccine
19515-816Flulaval Quadrivalentinfluenza virus vaccine
19515-818Flulaval Quadrivalentinfluenza virus vaccine
19515-897Flulaval Quadrivalentinfluenza virus vaccine
19515-900Flulaval Quadrivalentinfluenza virus vaccine
19515-906Flulaval Quadrivalentinfluenza virus vaccine
19515-909Flulaval Quadrivalentinfluenza virus vaccine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.